These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25812463)

  • 1. Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.
    Jean SS; Lee WS; Lam C; Hsu CW; Chen RJ; Hsueh PR
    Future Microbiol; 2015; 10(3):407-25. PubMed ID: 25812463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carbapenemases in gram-negative bacteria. Current data and trends of resistance resulting from the work of national reference centres].
    Kaase M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1401-4. PubMed ID: 23114438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals, Khartoum Sudan.
    Adam MA; Elhag WI
    BMC Infect Dis; 2018 Dec; 18(1):668. PubMed ID: 30558551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and descriptive analysis of carbapenemase-producing Gram-negative rod infections in Bogota, Colombia.
    Ibáñez-Prada ED; Bustos IG; Gamboa-Silva E; Josa DF; Mendez L; Fuentes YV; Serrano-Mayorga CC; Baron O; Ruiz-Cuartas A; Silva E; Judd LM; Harshegyi T; Africano HF; Urrego-Reyes J; Beltran CC; Medina S; Leal R; Stewardson AJ; Wyres KL; Hawkey J; Reyes LF
    Microbiol Spectr; 2024 Jun; 12(6):e0171423. PubMed ID: 38629835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin.
    Mathlouthi N; Al-Bayssari C; Bakour S; Rolain JM; Chouchani C
    Crit Rev Microbiol; 2017 Feb; 43(1):43-61. PubMed ID: 27387224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 9. Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence.
    Yuan P-B; Dai L-T; Zhang Q-K; Zhong Y-X; Liu W-T; Yang L; Chen D-Q
    Microbiol Spectr; 2024 Jul; 12(7):e0000824. PubMed ID: 38860788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria.
    Oueslati S; Girlich D; Dortet L; Naas T
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29305547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [News of antibiotic resistance among Gram-negative bacilli in Algeria].
    Baba Ahmed-Kazi Tani Z; Arlet G
    Pathol Biol (Paris); 2014 Jun; 62(3):169-78. PubMed ID: 24819127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of β-lactamase production in Gram-negative bacteria from Saudi Arabia.
    Yezli S; Shibl AM; Memish ZA
    J Med Microbiol; 2015 Feb; 64(Pt 2):127-136. PubMed ID: 25418734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of armA and rmtB genes among VIM, NDM, and IMP metallo-β-lactamase-producing multidrug-resistant Gram-negative pathogens.
    Gopalakrishnan S; Kamalanathan A; Rajan S; Bhagat VM; Ali MKS
    Acta Microbiol Immunol Hung; 2018 Mar; 65(1):107-118. PubMed ID: 28870092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.
    Bush K; Fisher JF
    Annu Rev Microbiol; 2011; 65():455-78. PubMed ID: 21740228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia.
    Ageevets VA; Partina IV; Lisitsyna ES; Ilina EN; Lobzin YV; Shlyapnikov SA; Sidorenko SV
    Int J Antimicrob Agents; 2014 Aug; 44(2):152-5. PubMed ID: 25059447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the epidemiology of carbapenemases in Latin America and the Caribbean.
    García-Betancur JC; Appel TM; Esparza G; Gales AC; Levy-Hara G; Cornistein W; Vega S; Nuñez D; Cuellar L; Bavestrello L; Castañeda-Méndez PF; Villalobos-Vindas JM; Villegas MV
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):197-213. PubMed ID: 32813566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.
    Boyle DP; Zembower TR
    Urol Clin North Am; 2015 Nov; 42(4):493-505. PubMed ID: 26475946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.